Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Prion protein attenuates excitotoxicity by inhibiting NMDA receptors
Houman Khosravani1,
Yunfeng Zhang1,
Shigeki Tsutsui2,
Shahid Hameed1,
Christophe Altier1,
Jawed Hamid1,
Lina Chen1,
Michelle Villemaire2,
Zenobia Ali2,
Frank R. Jirik2, , and
Gerald W. Zamponi1
1 Department of Physiology and Biophysics, Hotchkiss Brain Institute, and 2 Department of Biochemistry and Molecular Biology, McCaig Institute for Bone and Joint Health, University of Calgary, Calgary T2N4N1, Canada
Correspondence to Gerald W. Zamponi: zamponi{at}ucalgary.ca
Abstract:
It is well established that misfolded forms of cellular prionprotein (PrP [PrPC]) are crucial in the genesis and progressionof transmissible spongiform encephalitis, whereas the functionof native PrPC remains incompletely understood. To determinethe physiological role of PrPC, we examine the neurophysiologicalproperties of hippocampal neurons isolated from PrP-null mice.We show that PrP-null mouse neurons exhibit enhanced and drasticallyprolonged N-methyl-D-aspartate (NMDA)–evoked currentsas a result of a functional upregulation of NMDA receptors (NMDARs)containing NR2D subunits. These effects are phenocopied by RNAinterference and are rescued upon the overexpression of exogenousPrPC. The enhanced NMDAR activity results in an increase inneuronal excitability as well as enhanced glutamate excitotoxicityboth in vitro and in vivo. Thus, native PrPC mediates an importantneuroprotective role by virtue of its ability to inhibit NR2Dsubunits.
Abbreviations used in this paper: aCSF, artificial cerebrospinalfluid; APV, aminophosphonovaleric acid; DIV, day in vitro; fEPSP,field excitatory postsynaptic potential; GABA, -aminobutyricacid; mEPSC, miniature excitatory postsynaptic current; mIPSC,miniature inhibitory postsynaptic current; NMDA, N-methyl-D-aspartate;NMDAR, NMDA receptor; PrP, prion protein; TSE, transmissiblespongiform encephalopathy; TTX, tetrodotoxin; WT, wild type.
A Mutant Prion Protein Sensitizes Neurons to Glutamate-Induced Excitotoxicity.
E. Biasini, U. Unterberger, I. H. Solomon, T. Massignan, A. Senatore, H. Bian, T. Voigtlaender, F. P. Bowman, V. Bonetto, R. Chiesa, et al. (2013)
J. Neurosci.
33, 2408-2418
|Abstract »|Full Text »|PDF »
The Heat Shock Response Is Modulated by and Interferes with Toxic Effects of Scrapie Prion Protein and Amyloid {beta}.
U. K. Resenberger, V. Muller, L. M. Munter, M. Baier, G. Multhaup, M. R. Wilson, K. F. Winklhofer, and J. Tatzelt (2012)
J. Biol. Chem.
287, 43765-43776
|Abstract »|Full Text »|PDF »
Copper-dependent regulation of NMDA receptors by cellular prion protein: implications for neurodegenerative disorders.
Cellular prion protein is essential for oligomeric amyloid-{beta}-induced neuronal cell death.
W. Kudo, H.-P. Lee, W.-Q. Zou, X. Wang, G. Perry, X. Zhu, M. A. Smith, R. B. Petersen, and H.-g. Lee (2012)
Hum. Mol. Genet.
21, 1138-1144
|Abstract »|Full Text »|PDF »
Calpain-mediated Degradation of Myocyte Enhancer Factor 2D Contributes to Excitotoxicity by Activation of Extrasynaptic N-Methyl-D-aspartate Receptors.
G. Wei, Y. Yin, W. Li, H. Bito, H. She, and Z. Mao (2012)
J. Biol. Chem.
287, 5797-5805
|Abstract »|Full Text »|PDF »
A{beta} neurotoxicity depends on interactions between copper ions, prion protein, and N-methyl-D-aspartate receptors.
H. You, S. Tsutsui, S. Hameed, T. J. Kannanayakal, L. Chen, P. Xia, J. D. T. Engbers, S. A. Lipton, P. K. Stys, and G. W. Zamponi (2012)
PNAS
109, 1737-1742
|Abstract »|Full Text »|PDF »
Prion Protein Promotes Growth Cone Development through Reggie/Flotillin-Dependent N-Cadherin Trafficking.
V. Bodrikov, G. P. Solis, and C. A. O. Stuermer (2011)
J. Neurosci.
31, 18013-18025
|Abstract »|Full Text »|PDF »
Neuroprotection against Traumatic Brain Injury by a Peptide Derived from the Collapsin Response Mediator Protein 2 (CRMP2).
J. M. Brittain, L. Chen, S. M. Wilson, T. Brustovetsky, X. Gao, N. M. Ashpole, A. I. Molosh, H. You, A. Hudmon, A. Shekhar, et al. (2011)
J. Biol. Chem.
286, 37778-37792
|Abstract »|Full Text »|PDF »
Neuroprotective role of PrPC against kainate-induced epileptic seizures and cell death depends on the modulation of JNK3 activation by GluR6/7-PSD-95 binding.
P. Carulla, A. Bribian, A. Rangel, R. Gavin, I. Ferrer, C. Caelles, J. A. del Rio, and F. Llorens (2011)
Mol. Biol. Cell
22, 3041-3054
|Abstract »|Full Text »|PDF »
An N-terminal Polybasic Domain and Cell Surface Localization Are Required for Mutant Prion Protein Toxicity.
I. H. Solomon, N. Khatri, E. Biasini, T. Massignan, J. E. Huettner, and D. A. Harris (2011)
J. Biol. Chem.
286, 14724-14736
|Abstract »|Full Text »|PDF »
Cellular Prion Protein Promotes Regeneration of Adult Muscle Tissue.
R. Stella, M. L. Massimino, M. Sandri, M. C. Sorgato, and A. Bertoli (2010)
Mol. Cell. Biol.
30, 4864-4876
|Abstract »|Full Text »|PDF »
Neurotoxic Mutants of the Prion Protein Induce Spontaneous Ionic Currents in Cultured Cells.
I. H. Solomon, J. E. Huettner, and D. A. Harris (2010)
J. Biol. Chem.
285, 26719-26726
|Abstract »|Full Text »|PDF »
Isolation and Characterization of Patient-derived, Toxic, High Mass Amyloid {beta}-Protein (A{beta}) Assembly from Alzheimer Disease Brains.
A. Noguchi, S. Matsumura, M. Dezawa, M. Tada, M. Yanazawa, A. Ito, M. Akioka, S. Kikuchi, M. Sato, S. Ideno, et al. (2009)
J. Biol. Chem.
284, 32895-32905
|Abstract »|Full Text »|PDF »
All quiet on the neuronal front: NMDA receptor inhibition by prion protein.
Prion protein attenuates excitotoxicity by inhibiting NMDA receptors.
H. Khosravani, Y. Zhang, S. Tsutsui, S. Hameed, C. Altier, J. Hamid, L. Chen, M. Villemaire, Z. Ali, F. R. Jirik, et al. (2008)
J. Gen. Physiol.
131, i5
|Full Text »
Prion protein attenuates excitotoxicity by inhibiting NMDA receptors.
H. Khosravani, Y. Zhang, S. Tsutsui, S. Hameed, C. Altier, J. Hamid, L. Chen, M. Villemaire, Z. Ali, F. R. Jirik, et al. (2008)
J. Exp. Med.
205, i13
|Full Text »